1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics in Japan, May 2019

Chronic Disease Analysis & Statistics in Japan, May 2019

1-30 of about 200 reports

2019-2023 Competing in the Global Respiratory Diseases Diagnostic Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2019-2023 Competing in the Global Respiratory Diseases Diagnostic Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 9850
  • Industry report
  • March 2019

2019-2023 Competing in the Global Respiratory Diseases Diagnostic Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, ...

  • Industries : Pathology
  • Countries : United States, Europe, Japan, World
2019 Global Respiratory Diseases Diagnostic Testing Market: US, Europe, Japan--Supplier Shares by Test and Country, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers

2019 Global Respiratory Diseases Diagnostic Testing Market: US, Europe, Japan--Supplier Shares by Test and Country, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers

  • $ 7500
  • Industry report
  • April 2019

2019 Global Respiratory Diseases Diagnostic Testing Market: US, Europe, Japan--Supplier Shares by Test and Country, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation ...

  • Industries : Pathology, Chronic Disease, Medical Biotechnology, Diagnostics
  • Countries : World, United States, Europe, Japan
2019 Global Respiratory Diseases: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Sales Segment Forecasts--Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

2019 Global Respiratory Diseases: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Sales Segment Forecasts--Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

  • $ 6400
  • Industry report
  • March 2019

2019 Global Respiratory Diseases: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Sales Segment Forecasts--Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, ...

  • Industries : Pathology, Medical Biotechnology, Healthcare, Chronic Disease
  • Countries : World, United States, Europe, Japan
Global Diabetes Diagnostics Industry

Global Diabetes Diagnostics Industry

  • $ 5800
  • Industry report
  • May 2019

This report analyzes the worldwide markets for Diabetes Diagnostics in US$ by the following Product Segments: Continuous Glucose Monitoring (CGM) Systems, HbA1c Testing Devices, and Blood Glucose Monitoring ...

  • Industries : Chronic Disease, Pathology
  • Countries : World, APAC, United States, Japan, Europe
Global DNA Probes-Based Diagnostics Industry

Global DNA Probes-Based Diagnostics Industry

  • $ 5600
  • Industry report
  • May 2019

This report analyzes the worldwide markets for DNA Probes-Based Diagnostics in US$ Million by the following Application Areas: Infectious Diseases, Cancer Testing, Genetic Predisposition, Identity/Forensics, ...

  • Industries : Pathology, Cancer, Genomics Proteomics and Enabling Technology, Diagnostics, Chronic Disease
  • Countries : World, APAC, Japan, Europe, United States, Canada
2019-2023 Competing in the Japan Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2019-2023 Competing in the Japan Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 2400
  • Industry report
  • March 2019

2019-2023 Competing in the Japan Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and ...

  • Industries : Medical Biotechnology, Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics, Healthcare
  • Countries : Japan
Japan Diabetes Market Report: 2019-2024

Japan Diabetes Market Report: 2019-2024

  • $ 1999
  • Industry report
  • April 2019

The Japan diabetes market reached a value of more than US$ 4 Billion in 2018, registering a CAGR of 4.4% during 2011-2018. The market is further projected to cross US$ 5 Billion by 2024, growing at a CAGR ...

  • Industries : Chronic Disease, Pathology, Therapy
  • Countries : Japan
2019 Japan Respiratory Diseases Diagnostic Testing Market: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers

2019 Japan Respiratory Diseases Diagnostic Testing Market: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities for Suppliers

  • $ 1850
  • Industry report
  • April 2019

2019 Japan Respiratory Diseases Diagnostic Testing Market: Supplier Shares by Test, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Instrumentation Review, Opportunities ...

  • Industries : Medical Biotechnology, Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics, Healthcare
  • Countries : Japan
2019-2023 LDL Cholesterol Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

2019-2023 LDL Cholesterol Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

  • $ 750
  • Industry report
  • February 2019

2019-2023 LDL Cholesterol Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsThis new report from VPGMarketResearch provides analysis of LDL Cholesterol testing, ...

  • Industries : Health Services
  • Countries : United States, Japan
2019-2023 LDL Cholesterol Direct Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

2019-2023 LDL Cholesterol Direct Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

  • $ 750
  • Industry report
  • February 2019

2019-2023 LDL Cholesterol Direct Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC LocationsThis new report from VPGMarketResearch provides analysis of LDL Cholesterol ...

  • Industries : Health Services
  • Countries : United States, Japan
Poxel SA (POXEL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Poxel SA (POXEL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2018

SummaryPoxel SA (Poxel) is a biopharmaceutical company that focuses to develop drugs for metabolic diseases.The company’s pipeline product portfolio includes Imeglimin, which is developed to target mitochondrial ...

  • Industries : Pharmaceutical, Therapy, Medical Biotechnology
  • Countries : Japan, United States
Allergies Global Clinical Trials Review, H2, 2018

Allergies Global Clinical Trials Review, H2, 2018

  • $ 2500
  • Industry report
  • October 2018

Allergies Global Clinical Trials Review, H2, 2018SummaryGlobalData’s clinical trial report, “Allergies Global Clinical Trials Review, H2, 2018" provides an overview of Allergies clinical trials scenario.This ...

  • Industries : Pharmaceutical, Drug Development, Medical Biotechnology
  • Countries : World, Japan
Kyowa Hakko Kirin Co Ltd (4151) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kyowa Hakko Kirin Co Ltd (4151) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryKyowa Hakko Kirin Co Ltd (Kyowa Hakko), a subsidiary of Kirin Holdings Company Limited, is a research and development (R&D) based biotechnology company.It focuses on the discovery, development, ...

  • Industries : Pharmaceutical, Medical Biotechnology
  • Countries : Japan, United States
Athersys Inc (ATHX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Athersys Inc (ATHX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • October 2018

SummaryAthersys Inc (Athersys) is a biotechnology company that discovers and develops of novel and proprietary best-in-class therapies in the field of regenerative medicine.Its lead platform, MultiStem, ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Chronic Disease, Pharmaceutical
  • Countries : Japan
Cedar Pollen Allergy - Pipeline Review, H2 2018

Cedar Pollen Allergy - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • September 2018

Cedar Pollen Allergy - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Cedar Pollen Allergy - Pipeline Review, H2 2018, provides an ...

  • Industries : Therapy, Chronic Disease, Pharmaceutical, Pathology, Medical Biotechnology
  • Countries : Japan, World
Global Biosensors Industry

Global Biosensors Industry

  • $ 5600
  • Industry report
  • August 2018

This report analyzes the worldwide markets for Biosensors in US$ Thousand by the following Product Applications: Medical Biosensors (Glucose Biosensors, & Other Medical Biosensors), Environmental Biosensors, ...

  • Industries : Chronic Disease, Industrial Biotechnology, Pathology, Software
  • Countries : APAC, World, Japan, United States, Europe
Acute Ischemic Stroke: Epidemiology Forecast to 2027

Acute Ischemic Stroke: Epidemiology Forecast to 2027

  • $ 3995
  • Industry report
  • July 2018

Acute Ischemic Stroke: Epidemiology Forecast to 2027SummaryAcute Ischemic Stroke (AIS) occurs due to an obstructed blood vessel that supplies blood to the brain, and is the predominant type of stroke, ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States, China, World, United Kingdom, Japan
Ono Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Ono Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • July 2018

Ono Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Ono Pharmaceutical Co., Ltd. Mergers & Acquisitions (M&A), Partnerships ...

  • Industries : Pharmaceutical
  • Countries : Japan, United States
Shionogi & Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Shionogi & Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • July 2018

Shionogi & Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Shionogi & Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and ...

  • Industries : Pharmaceutical, Health Services
  • Countries : United States, Japan
Kirin Holdings Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Kirin Holdings Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • July 2018

Kirin Holdings Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Kirin Holdings Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and ...

  • Industries : Pharmaceutical, Therapy, Health Services, Pathology
  • Countries : Japan
Upsher-Smith Laboratories Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Upsher-Smith Laboratories Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • July 2018

Upsher-Smith Laboratories Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Upsher-Smith Laboratories Inc Mergers & Acquisitions (M&A), Partnerships ...

  • Industries : Health Services, Therapy, Pharmaceutical, Pathology, Healthcare
  • Countries : United States, United Kingdom, Japan
Meiji Seika Pharma Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Meiji Seika Pharma Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • July 2018

Meiji Seika Pharma Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Meiji Seika Pharma Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances ...

  • Industries : Pharmaceutical, Health Services, Pathology, Therapy
  • Countries : Japan
Eisai Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Eisai Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • July 2018

Eisai Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Eisai Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments ...

  • Industries : Health Services, Therapy, Pathology, Pharmaceutical, Healthcare
  • Countries : Japan, United States
Mitsubishi Tanabe Pharma Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Mitsubishi Tanabe Pharma Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • July 2018

Mitsubishi Tanabe Pharma Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Mitsubishi Tanabe Pharma Corporation Mergers & Acquisitions (M&A), ...

  • Industries : Pharmaceutical, Therapy
  • Countries : Japan, Canada
Astellas Pharma Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Astellas Pharma Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • July 2018

Astellas Pharma Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Astellas Pharma Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and ...

  • Industries : Pharmaceutical, Health Services, Pathology, Therapy
  • Countries : Japan, United States
Acute Ischemic Stroke: Global Drug Forecast and Market Analysis to 2027

Acute Ischemic Stroke: Global Drug Forecast and Market Analysis to 2027

  • $ 10995
  • Industry report
  • July 2018

Acute Ischemic Stroke: Global Drug Forecast and Market Analysis to 2027SummarySales of drugs in the AIS market (including TIA) were approximately $7.2B in 2017 in the 8MMthe US, five major European countries ...

  • Industries : Therapy, Chronic Disease, Pathology, Pharmaceutical
  • Countries : United States, East Asia, China, Japan, North America
Sumitomo Dainippon Pharma Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Sumitomo Dainippon Pharma Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2018

Sumitomo Dainippon Pharma Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Sumitomo Dainippon Pharma Co., Ltd. Mergers & Acquisitions (M&A), ...

  • Industries : Pharmaceutical, Therapy
  • Countries : Japan
Chugai Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Chugai Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2018

Chugai Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Chugai Pharmaceutical Co., Ltd. Mergers & Acquisitions (M&A), Partnerships ...

  • Industries : Pharmaceutical
  • Countries : Japan
2018 Global Respiratory Diseases Diagnostic Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2018 Global Respiratory Diseases Diagnostic Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 6200
  • Industry report
  • June 2018

This new 366-page report .com contains 108 tables and provides analysis of the global respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, ...

  • Industries : Pathology, Medical Biotechnology, Diagnostics, Chronic Disease
  • Countries : United States, Europe, Japan, World
2018 Japan Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2018 Japan Respiratory Diseases Diagnostic Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 1500
  • Industry report
  • June 2018

About This ReportThis new 282-page report .com presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, ...

  • Industries : Medical Biotechnology, Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics, Healthcare
  • Countries : Japan

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on